Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer

Clinical Colorectal Cancer- United States

doi 10.1016/j.clcc.2015.11.004

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2019English

Interim Analysis of Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase III Trial

Oncotarget
Oncology
2016English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer

JAMA - Journal of the American Medical Association
Medicine
2012English

Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Capecitabine Plus Oxaliplatin Compared With 5-Fluorouracil Plus Oxaliplatin in Metastatic Colorectal Cancer: Meta-Analysis of Randomized Controlled Trials

Oncology Letters
Cancer ResearchOncology
2012English

Capecitabine and Oxaliplatin (XELOX) Is Safe and Effective in Patients With Advanced Gastric Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2007English

Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine

Clinical Colorectal Cancer
OncologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy